<DOC>
	<DOCNO>NCT02791035</DOCNO>
	<brief_summary>The purpose study examine correlation change HbA1c , urinary glucose excretion factor ipragliflozin add preexist therapy subject type 2 diabetes .</brief_summary>
	<brief_title>Correlation Between Change HbA1c , Urinary Glucose Excretion Other Factors Patients Treated With Ipragliflozin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Subject write informed consent Subjects diagnose type 2 diabetes mellitus Subjects 20 70 year old Subjects stable diet exercise least 8 week prior study participation Stable dos follow medication 8 week , HbA1c level 7.0 9.5 % ( Metformin , Metformin + SU , Metformin + DPP4 inhibitor , Metformin + TZD , TZD , TZD + SU , TZD + DPP4 inhibitor , SU , SU + DPP4 inhibitor , DPP4 inhibitor ) Type 1 DM Gestational DM Diabetic ketoacidosis CKD stage 3B5 ( eGFR 45 ) Severe infection , serious trauma , perioperative period Known suspect hypersensitivity ipragliflozin Symptomatic urogenital infection Chemotherapy radiation therapy malignant tumor diagnosis malignant tumor within 5 year ( except thyroid cancer ) Under therapeutic intervention and/or another clinical study use IP drug Hepatic disease ( 3 time upper normal limit AST ALT ) Serious void difficulty due neurogenic bladder prostate hyperplasia Drugs allow concomitant use Alpha glucosidase inhibitor meglitinide within 60 day prior screen Insulin within 60 day prior screen Systemic steroid use ( PO , IV IM ) 2 week within 3 month prior screen Inhalation pleural intracavitary injection steroid know high systemic absorption rate GLP1 agonist ( except exenatide ) within 60 day prior screen Heart failure ( NYHA class IIIIV ) uncontrolled arrhythmia within 6 month prior screen Cardiovascular disease ( unstable angina , myocardial infarction , transient ischemic attack , cerebrovascular disease , coronary artery bypass graft , percutaneous coronary intervention ) within 3 month prior screen Subjects eligible study accord investigator 's decision Inability read consent form Pregnancy , lactation , plan get pregnant study period</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>